Clinical Trials on Raynaud's Phenomenon (Secondary)
Total 1549 results
-
Benha UniversityNew Jeddah Clinic HospitalCompletedDiabetic Nephropathies | Secondary Hyperparathyroidism
-
The University of Hong KongAbbVieUnknownSecondary Hyperparathyroidism | Endstage Renal DiseaseHong Kong
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
ENRICO VERRINAUnknownSecondary HyperparathyroidismItaly
-
AbbottCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AmgenCompletedSecondary HyperparathyroidismChina
-
Ain Shams UniversityCompleted
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Smith & Nephew Orthopaedics AGCompletedPrimary and Secondary Omarthrosis
-
Soonchunhyang University HospitalSeoul National University Hospital; SMG-SNU Boramae Medical Center; Saint Vincent... and other collaboratorsRecruitingNeoplasms | Secondary Malignant NeoplasmKorea, Republic of
-
Sheba Medical CenterZotal Inc.UnknownNo-Reflow Phenomenon | STEMI - ST Elevation Myocardial InfarctionIsrael
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention...CompletedPain | Healthy Volunteers | Magnetic Resonance Imaging | Secondary HyperalgesiaDenmark
-
First Affiliated Hospital of Chengdu Medical CollegeRecruitingPrimary Aldosteronism | Resistant Hypertension | Secondary Hypertension | Secondary Hypertension to Endocrine DisordersChina
-
Chengdu Suncadia Medicine Co., Ltd.Not yet recruiting
-
AbbVie (prior sponsor, Abbott)CompletedEvaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)Chronic Kidney Disease | Secondary HyperparathyroidismBulgaria, Czech Republic, Romania
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
-
Universitaire Ziekenhuizen KU LeuvenCompletedHematologic Diseases | Secondary Immune DeficiencyBelgium
-
St. Franziskus HospitalUniversity of Erlangen-Nürnberg Medical SchoolCompletedUveitis | Secondary GlaucomaGermany
-
Casa Sollievo della Sofferenza IRCCSNeurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...CompletedSecondary-progressive Multiple SclerosisItaly, Switzerland
-
University of Colorado, DenverCompletedBurnout | Self-compassion | Moral Injury | Impostor PhenomenonUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
University of AarhusCompletedRoux-en-Y Gastric Bypass | Hyperparathyroidism, SecondaryDenmark
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
Skane University HospitalKarolinska Institutet; Lund University; University of Copenhagen; University of...RecruitingPsoriasis | Psoriasis; Arthritis (Etiology) | Koebner PhenomenonSweden
-
Western University, CanadaActive, not recruiting
-
Hannover Medical SchoolGerman Research FoundationTerminatedSecondary Sclerosing CholangitisGermany
-
Zagazig UniversityUnknown
-
University of UtahCompletedMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Secondary Progressive Multiple SclerosisUnited States
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Secondary Hyperparathyroidism | Stage 5 Chronic Kidney Diseases
-
AmgenCompletedSecondary Hyperparathyroidism in Patients With ESRD on HemodialysisUnited States
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AbbVie (prior sponsor, Abbott)CompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbottAbbott Japan Co.,LtdCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
Tomsk National Research Medical Center of the Russian...CompletedST Elevation Myocardial Infarction | Percutaneous Coronary Intervention | No-Reflow PhenomenonRussian Federation
-
Case Comprehensive Cancer CenterNot yet recruitingPseudomyxoma Peritonei | Secondary Malignant Neoplasm of Peritoneum | Secondary Malignant Neoplasm of RetroperitoneumUnited States
-
OPKO Health, Inc.Active, not recruitingChronic Kidney Diseases | Vitamin D Deficiency | Stage 5 Chronic Kidney Disease | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
Ottawa Hospital Research InstituteNot yet recruiting
-
Hospital of South West JutlandCompletedMedication-overuse Headache | Secondary Headache Disorders
-
Geron CorporationCompletedPrimary Myelofibrosis | Secondary Myelofibrosis | Myeloid MalignanciesUnited States
-
Novartis PharmaceuticalsActive, not recruitingActive Secondary Progressive Multiple SclerosisItaly
-
Novartis PharmaceuticalsTerminatedSecondary Progressive Multiple Sclerosis With Inflammatory Disease ActivitySwitzerland